202 related articles for article (PubMed ID: 17435644)
1. Are various Babesia species a missed cause for hypereosinophilia? A follow-up on the first reported case of imatinib mesylate for idiopathic hypereosinophilia.
Schaller JL; Burkland GA; Langhoff PJ
MedGenMed; 2007 Feb; 9(1):38. PubMed ID: 17435644
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome.
Payne SM; Kovacs MJ
Ann Pharmacother; 2004; 38(7-8):1215-8. PubMed ID: 15187212
[TBL] [Abstract][Full Text] [Related]
3. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.
Schaller JL; Burkland GA
MedGenMed; 2001 Sep; 3(5):9. PubMed ID: 11698916
[TBL] [Abstract][Full Text] [Related]
4. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
Garg A; Duggal L; Aggarwal S; Jain N
J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
[TBL] [Abstract][Full Text] [Related]
5. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
Smith KJ; Jacobson E; Hamza S; Skelton H
Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
[TBL] [Abstract][Full Text] [Related]
6. Fever of unknown origin (FUO) due to babesiosis in a immunocompetent host.
Cunha BA; Cohen YZ; McDermott B
Heart Lung; 2008; 37(6):481-4. PubMed ID: 18992633
[TBL] [Abstract][Full Text] [Related]
7. Imatinib-responsive hypereosinophilia in a patient with B cell ALL.
Robyn J; Noel P; Wlodarska I; Choksi M; O'neal P; Arthur D; Dunbar C; Nutman T; Klion A
Leuk Lymphoma; 2004 Dec; 45(12):2497-501. PubMed ID: 15621767
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate: a case report.
Tan D; Hwang W; Ng HJ; Goh YT; Tan P
Int J Hematol; 2004 Jul; 80(1):75-7. PubMed ID: 15293573
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.
Vyas JM; Telford SR; Robbins GK
Clin Infect Dis; 2007 Dec; 45(12):1588-90. PubMed ID: 18190320
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate for the treatment of hypereosinophilic syndromes.
Antoniu SA
Curr Opin Investig Drugs; 2006 Nov; 7(11):980-4. PubMed ID: 17117585
[TBL] [Abstract][Full Text] [Related]
11. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
Hofmann SC; Technau K; Müller AM; Lübbert M; Bruckner-Tuderman L
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S68-72. PubMed ID: 17097375
[TBL] [Abstract][Full Text] [Related]
13. The hypereosinophilic syndromes: still more heterogeneity.
Gleich GJ; Leiferman KM
Curr Opin Immunol; 2005 Dec; 17(6):679-84. PubMed ID: 16214314
[TBL] [Abstract][Full Text] [Related]
14. First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen.
Häselbarth K; Tenter AM; Brade V; Krieger G; Hunfeld KP
Int J Med Microbiol; 2007 Jun; 297(3):197-204. PubMed ID: 17350888
[TBL] [Abstract][Full Text] [Related]
15. Reader's response to "Rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate".
Shinkarow JW
MedGenMed; 2007; 9(1):39. PubMed ID: 17441290
[No Abstract] [Full Text] [Related]
16. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.
Roche-Lestienne C; Lepers S; Soenen-Cornu V; Kahn JE; Laï JL; Hachulla E; Drupt F; Demarty AL; Roumier AS; Gardembas M; Dib M; Philippe N; Cambier N; Barete S; Libersa C; Bletry O; Hatron PY; Quesnel B; Rose C; Maloum K; Blanchet O; Fenaux P; Prin L; Preudhomme C
Leukemia; 2005 May; 19(5):792-8. PubMed ID: 15772698
[TBL] [Abstract][Full Text] [Related]
17. Atovaquone and azithromycin treatment for babesiosis in an infant.
Raju M; Salazar JC; Leopold H; Krause PJ
Pediatr Infect Dis J; 2007 Feb; 26(2):181-3. PubMed ID: 17259886
[TBL] [Abstract][Full Text] [Related]
18. [The hypereosinophilic syndrome: case report].
Mikołajczyk K; Zaba R; Walkowiak B; Grzybowski G; Samborski W
Ann Acad Med Stetin; 2006; 52 Suppl 2():65-9. PubMed ID: 17471838
[TBL] [Abstract][Full Text] [Related]
19. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
[TBL] [Abstract][Full Text] [Related]
20. Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinib.
Garcia-Alvarez A; Sitges M; Garcia-Albeniz X; Sionis A; Loma-Osorio P; Bosch X
Int J Cardiol; 2010 Mar; 139(2):e29-31. PubMed ID: 19056137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]